[1]
HEENA PEETHAMBARAN et al. 2025. MOLECULAR DOCKING STUDIES OF NEW ANTIHYPERTENSIVE DRUG BASED ON DELPHINIDIN-3-SAMBUBIOSIDE ANALOGUES USING ANTIOGENSIN I–CONVERTING ENZYME AS THE TARGET. Asian Journal of Pharmaceutical and Clinical Research. 18, 6 (Jun. 2025), 117–123. DOI:https://doi.org/10.22159/ajpcr.2025v18i6.54657.